Source: Beidaihe New District
The Management Committee of Beidaihe New District has successfully signed a contract with Dawan Hanwei (Guangzhou) Pharmaceutical Science and Technology Group Co., Ltd., founded by the academician Liu Changxiao of the Chinese Academy of Engineering. The international New Drug Evaluation and Clinical Transformation Project of the Whole Chain Medical and Health Care Industry, conducted by academician Liu Changxiao, officially settled in Beidaihe New District.
Dawan Hanwei (Guangzhou) Pharmaceutical Science and Technology Group Co., Ltd. is a chain medical and health care industry group, founded by academician Liu Changxiao. The total investment of the signed project is about 3.51 billion yuan, including 4 sub-projects: International New Drug Chain Evaluation Public Technology Platform, Research Clinical Hospital, Chinese Academy of Traditional Chinese Medicine (Beidaihe) National Hospital, Global New Medical and Health Care Community and so on.
The project construction is based on the concept of “combining treatment and medicine, and paying equal attention to medication and drugs”, integrating “medication, medicine, health care and fun”. We will create the first whole chain drug evaluation platform in China, establish a whole chain evaluation mode from laboratory results to clinical validation and feedback to laboratory, promote clinical individualized treatment with transitional research, enrich the layout of life and health industry in the demonstration area, and bring continuous motivation for the development of the demonstration area.
International Channel
http://www.qhdnews.com/en/index/
International Channel Mobile Client
http://www.qhdnews.com/en/mobile
Chinese manuscript